Albumin-Templated Bi 2 Se 3 –MnO 2 Nanocomposites with Promoted Catalase-Like Activity for Enhanced Radiotherapy of Cancer
Yuzhu Yao,Puze Li,Junkai He,Dongdong Wang,Jun Hu,Xiangliang Yang
DOI: https://doi.org/10.1021/acsami.1c05669
2021-06-14
Abstract:Novel and effective radiosensitizers that can enhance radiosensitivity of tumor tissues and increase the local radiation dose are highly desirable. In this work, templated by bovine serum albumin (BSA), Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub> nanocomposites (Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA) were fabricated via biomineralization, while Bi<sub>2</sub>Se<sub>3</sub> nanodots act as radiosensitizers to increase the local radiation dosage because of their strong X-ray attenuation ability, and MnO<sub>2</sub> with catalase-like activity can increase the oxygen concentration in tumors by triggering the decomposition of tumor endogenous H<sub>2</sub>O<sub>2</sub> so as to improve the hypoxia-associated radioresistance of tumors. Owing to the interaction of the two components in the interface, Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA showed promoted catalytic activity compared to MnO<sub>2</sub>@BSA, favoring tumor radiotherapy (RT) sensitization. BSA templating enabled the nanocomposites with high colloidal stability and biocompatibility as well as satisfactory tumor targeting both in vitro and in vivo; thus, an enhanced RT efficacy was obtained. Moreover, the proposed Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA exhibited excellent performances in computerized tomography and magnetic resonance imaging. Thus, this work provides a tumor microenvironment-responsive multifunctional theranostic nanoagent with an improved performance for imaging-guided tumor RT sensitization.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.1c05669?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.1c05669</a>.Magnified TEM image of Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA; the hydrodynamic particle size of Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA in PBS, RPMI 1640 medium, and RPMI 1640 medium supplemented with 10% FBS after different incubation times (0, 0.5, 1, 2, and 4 h); colloidal stability of Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA NPs; XPS spectra of Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA; characterization of CAT-like activity of MnO<sub>2</sub>@BSA and Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA; initial oxygen generation in H<sub>2</sub>O<sub>2</sub> solutions (100 mM) by adding Bi<sub>2</sub>Se<sub>3</sub>@BSA, MnO<sub>2</sub>@BSA, and Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA NPs at different concentrations; cell apoptosis and necrosis of 4T1 cells after different treatments conducted by flow cytometry analysis; clonogenic SF of 4T1 cells treated with or without Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA under X-ray at doses of 0, 2, 4, 6, and 8 Gy; hemolysis percentages of Bi<sub>2</sub>Se<sub>3</sub>–MnO<sub>2</sub>@BSA NPs in normal saline at concentrations of 15.6, 31.3, 62.5, 125, 250, and 500 μg mL<sup>–1</sup>; HE staining of the heart, liver, spleen, lung, and kidney sections dissected from mice on the 13th day post various treatments (<a class="ext-link" href="/doi/suppl/10.1021/acsami.1c05669/suppl_file/am1c05669_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology